Cart
sales@molnova.com
Delphinidin-3-sambubioside chloride
CAS No. 53158-73-9
Delphinidin-3-sambubioside chloride( —— )
Catalog No. M31225 CAS No. 53158-73-9
Delphinidin-3-sambubioside chloride has antioxidant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 550 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDelphinidin-3-sambubioside chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDelphinidin-3-sambubioside chloride has antioxidant activity.
-
DescriptionDelphinidin-3-sambubioside chloride has antioxidant activity.
-
In VitroDelphinidin-3-sambubioside chloride (50-200 μM, 30 min) inhibits LPS-induced iNOS expression in RAW264.7 cells.Delphinidin-3-sambubioside chloride (50-200 μM, 30 min) suppresses the phosphorylation of ERK1/2 and MEK1/2 in RAW264.7 cells.Delphinidin-3-sambubioside chloride (50-200 μM, 30 min) downregulates NF-κB signaling pathway in RAW264.7 cells.Delphinidin-3-sambubioside chloride (24 h) inhibits HL-60 cells proliferation by inducing apoptosis, with an IC50 of 75 μM.Delphinidin-3-sambubioside chloride (100-200 μg/mL, 24 h) decreases intracellular TG levels and lipid accumulation in oleic acid-treated HepG2 cells. Western Blot Analysis Cell Line:RAW264.7 cells Concentration:50, 100, 200 μM Incubation Time:30 min Result:Suppressed the degradation of IκB, and the phosphorylation of p65.
-
In VivoDelphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) inhibits mouse paw edema induced by LPS.Delphinidin-3-sambubioside chloride (30 mg/kg body, oral gavage, daily for eight weeks) decreases lipid accumulation in HFD rats. Animal Model:Delphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) .Dosage:15 μmol/kg Administration:Intraperitoneal injection (i.p.), for 4 days.Result:Reduced the LPS-induced paw thickness. Decreased the edema by 89.3%.Decreased the levels of LPS induced serum IL-6, MCP-1 and TNF-α.Animal Model:HFD-fed rats Dosage:30 mg/kg Administration:Oral gavage, daily for eight weeks.Result:Reduced the body weight gain, visceral fat, and abdominal fat and decreased hepatic lipid deposits.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53158-73-9
-
Formula Weight633
-
Molecular FormulaC26H29O16Cl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
YX-2-107
YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.
-
3-O-Acetyl-16 alpha-...
3-O-Acetyl-16 alpha-hydroxytrametenolic acid has inhibitory activities against AAPH-induced hemolysis of red blood cells, it shows a strong inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.
-
OD1
Potent rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator (EC50 values are 7, 10 and 47 nM, respectively). Exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5 (EC50 values >3 μM). Inhibits fast inactivation on all channels. Increases peak currents at all voltages and stimulates a persistent Na+ current at hNav1.7 channel. Increases hyperpolarization at Nav1.4 and Nav1.6 channels. Induces spontaneous pain in vivo.
